If you’re supporting a friend or family member who is undergoing cancer treatment, you may not think of yourself as a “caregiver.” It’s a role that can be very rewarding, but also challenging and stressful.
You may find yourself juggling an incredible range of duties above and beyond what you regularly do at home and at work. From driving your loved one to appointments, to discussing medical issues with health care professionals, to making dinner every night, you may find that you’re taking care of nearly everything – except yourself.
But your loved one’s well-being depends on you, so it’s important that you also take care of yourself. Nancy Borstelmann, LICSW, MPH, a licensed clinical social worker who serves as Dana-Farber’s director of patient and family support and education, shares some tips that may help. Read more
Imagine being 22 and having your two biggest fears come true: You have cancer, and your treatment may leave you unable to have children in the future.
While you’re still coming to terms with the diagnosis, you now have to make some major life decisions. Do you want to freeze your eggs? Or should you choose a sperm donor and freeze fertilized eggs instead? Don’t forget to consider your husband’s feelings — even though he isn’t even in your life yet. Read more
Sunscreen shouldn’t be packed away just because it’s winter. Your skin can be exposed to harmful rays all year long. So before you hit the slopes, build a snowman, or head off to a tropical beach, take time to protect yourself, say skin cancerspecialists at Dana-Farber.
According to the American Cancer Society, snow, ice, and water can all reflect the ultraviolet radiation that causes sunburn, which in turn increases the risk of developing skin cancer. Some experts say winter sports enthusiasts face just as much risk of getting sunburn as summer sunbathers. Read more
Recent concerns about availability and authenticity of certain drugs have generated news headlines worldwide and raised anxiety levels for some cancer patients and their families.
Sylvia Bartel, RPh, MHP, Dana-Farber’s vice president of Pharmacy, says that although the cause of the two problems is unrelated, it underscores the need for continuous and careful monitoring and management of the Institute’s medications. Read more
These beams frame the building, but patients and families have lent far more than their names to the facility’s creation.
Their guidance underpins almost every aspect of the Yawkey Center. From the healing garden to the layout of exam rooms to the parking garage, the imprint of our patients and families is felt across the Institute.
Here, Janet Porter, PhD, chief operating officer, recalls in her own words the benefits of working closely with patients and families. Read more
On International Childhood Cancer Day, it’s important to remember that global support, research, and treatment are vital to ensuring that children in developing countries have the same chance at survival as their peers in the U.S. Physicians such as Dr. Leslie Lehmann from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center travel all over the world to deliver expert, curative care to young patients with cancer. Here is her story.
Rwanda is a tiny country in central Africa with much beauty but few resources. The genocide in 1994 that killed nearly a million people also devastated the health care system. Many people do not receive basic health care services and cancer care was nonexistent. It was impossible to even tell how common cancer was – people would die from a mass, or from bleeding, or infection without ever having a diagnosis.
The country has over 11 million people with not a single physician trained in caring for people with cancer. It’s a very sad situation.
This is beginning to change a bit. Through the Partners in Health (PIH) organization, I became part of a U.S.– Rwandan team led by Sara Stulac, PIH’s director of pediatrics, assembled at the Rwinkwavu hospital with the goal of providing consistent quality care to children with cancer. Sara had lived in Rwanda working at this rural PIH- sponsored hospital for six years. I went to Rwanda with Kathleen Houlahan, a pediatric oncology nurse and nurse director of the Jimmy Fund Clinic at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, and Dr. Larry Shulman, medical oncologist and chief medical officer of Dana-Farber, who is Senior Oncology Adviser for PIH and leads Dana-Farber/Brigham and Women’s Cancer Center efforts in Rwanda. Read more
Two husband and wife teams set a date every two weeks to do something special together. Not dinner and a movie, or a romantic night on the town: Barbara and Arthur Miller and Geri and John Ryan come in to Dana-Farber’s Kraft Family Blood Donor Center every two weeks to donate life-saving platelets. Platelets are the clotting agents of the blood and are critical for helping cancer patients return to health. Here’s their story.
Dana-Farber, with our partners Brigham and Women’s Hospital and Boston Children’s Hospital, offers patients highly advanced treatments in modern facilities. Our patients also benefit from an excellent staff, clinical research, and extensive resources, and many of them survive cancer to live long and healthy lives.
Is it fair, then, that cancer remains a death sentence elsewhere in the world? In Rwanda, for example, a country of 10 million people, cancer care has been completely unavailable to almost all patients. They die of cancers that could have been cured in Boston. Read more
Treatment with three relatively new “targeted” cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber.
The study looked at three drugs: sorafenib (Nexavar), sunitinib (Sutent), and pazopanib (Votrient). Sorafenib is approved to treat kidney and liver cancer, sunitinib to treat kidney cancer and gastrointestinal stromal tumor (GIST), and pazopanib to treat kidney cancer.
Dr. Toni Choueiri, the lead author of the study, says that patients should be aware of the risks and speak with their doctor.